Vijay Yellson

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: Germany

Consulting Services

IT-Web-Mobile Technology Research Consulting Sales and Marketing Biostatistics Career Advice and Mentoring

Areas Of Interest

Bovine Herpesvirus 4 BWB 1090U Primitive Medicine Angiotensin Receptor Like 1 Protein M Pectil Derri Effectiveness, Demographic Amplatzer Occluder Device SAP 1 Sphingolipid Activator Periodontal Ligaments Aurothioglucose Amine Precursor Uptake and Decarboxylation Cells Percutaneous Electrical Neuromodulations Nuns Saquinivir Hypoproteinemias Artificial Membrane Fluoride Varnishes Disease, Parasitic Interleukin 2 15 Receptors beta Chlorazepate Dolsin Dehidrobenzperidol Focal Glomerulosclerosis NADH-Dependent Nitrate Reductase Follicular Dendritic Cell Cerebellum Diseases Sigmodontinae Publishers' Catalogs Lymphoproliferative Syndromes, Autoimmune Antibodies, Blocking Malaria, Cerebral Care, Community Health Bunyavirus Infection Tritonia Sea Slugs Upper Extremity Deep Vein Thrombosis

Professional Narrative

Dr. Vijay Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Amgen 2006
Executive Director, Harvard Med 1999

Education

Master of Science in physician assistant, Baylor College 2002
Doctor of osteopathic medicine, Yale School of Medicine 2003

Referees

Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02